Literature DB >> 8603098

Regulation of energy metabolism by interleukin-1beta, but not by interleukin-6, is mediated by nitric oxide in primary cultured rat hepatocytes.

H Kitade1, T Kanemaki, K Sakitani, K Inoue, Y Matsui, T Kamiya, M Nakagawa, Y Hiramatsu, Y Kamiyama, S Ito, T Okumura.   

Abstract

The effects of inflammatory cytokines (interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha) on energy metabolism were studied in primary cultured rat hepatocytes. Adenine nucleotide (ATP, ADP, and AMP) content, lactate production, the ketone body ratio (acetoacetate/beta-hydroxybutyrate) reflecting the liver mitochondrial redox state (NAD+/NADH), and nitric oxide formation were measured. Insulin increased ATP content in hepatocytes and had a maximal effect after 8-12 h of culture. Both interleukin-1beta and interleukin-6, but not tumor necrosis factor-alpha, significantly inhibited the ATP increase time- and dose-dependently. Interleukin-1beta and interleukin-6 also stimulated lactate production. During the same period, interleukin-1beta but not interleukin-6 decreased the ketone body ratio. Furthermore, interleukin-1beta markedly stimulated nitric oxide formation in hepatocytes, and this increase was blocked by NG-monomethyl-L-arginine (a nitric oxide synthase inhibitor) and by interleukin-1 receptor antagonist. NG-monomethyl-L-arginine reversed inhibition of the ATP increase, decrease in the ketone body ratio, and increase in lactate production, which were induced by interleukin-1beta. Interleukin-1 receptor antagonist completely abolished all of the effects induced by interleukin-1beta. These results demonstrated that interleukin-1beta and interleukin-6 affect the insulin-induced energy metabolism in rat hepatocytes by different mechanisms. Specifically, interleukin-1beta inhibits ATP synthesis by causing the mitochondrial dysfunction, a process which may be mediated by nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603098     DOI: 10.1016/0167-4889(95)00188-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  The role of proinflammatory cytokines in inflammatory and metabolic responses.

Authors:  R G Tompkins
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

2.  Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment.

Authors:  Pascal Richette; Marie-France Dumontier; Khadija Tahiri; Magdalena Widerak; Antoine Torre; Mourad Benallaoua; Mourad Benallaloua; François Rannou; Marie-Therese Corvol; Jean-François Savouret
Journal:  Ann Rheum Dis       Date:  2006-10-26       Impact factor: 19.103

3.  A simplified model of hypoxic injury in primary cultured rat hepatocytes.

Authors:  T Kamiya; A H Kwon; T Kanemaki; Y Matsui; S Uetsuji; T Okumura; Y Kamiyama
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

4.  Action of E. coli endotoxin, IL-1beta and TNF-alpha on antioxidant status of cultured hepatocytes.

Authors:  Myriam Catalá; M Teresa Portolés
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

Review 5.  Metabolic host response and therapeutic approaches to influenza infection.

Authors:  Mohsen Keshavarz; Farid Solaymani-Mohammadi; Haideh Namdari; Yaser Arjeini; Mohammad Javad Mousavi; Farhad Rezaei
Journal:  Cell Mol Biol Lett       Date:  2020-03-05       Impact factor: 5.787

Review 6.  TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism.

Authors:  Christopher R Shepard
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-29       Impact factor: 5.555

7.  Mimitin - a novel cytokine-regulated mitochondrial protein.

Authors:  Paulina Wegrzyn; Stephen J Yarwood; Nathalie Fiegler; Monika Bzowska; Aleksander Koj; Danuta Mizgalska; Stanisław Malicki; Magdalena Pajak; Aneta Kasza; Neli Kachamakova-Trojanowska; Joanna Bereta; Jacek Jura; Jolanta Jura
Journal:  BMC Cell Biol       Date:  2009-03-31       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.